Biotika AS (XBRA:1BSL01AE) Net Income From Continuing Operations : €0.71 Mil (TTM As of Jun. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Biotika AS Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Biotika AS's net income from continuing operations for the six months ended in Jun. 2023 was €0.71 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was €0.71 Mil.

Biotika AS Net Income From Continuing Operations Historical Data

The historical data trend for Biotika AS's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotika AS Net Income From Continuing Operations Chart

Biotika AS Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Income From Continuing Operations

Get a 7-Day Free Trial

1.48

2.50

2.73

0.52

-0.84

Biotika AS Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Net Income From Continuing Operations	Get a 7-Day Free Trial															0.52	-0.60	-0.84	-	0.71

Biotika AS Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.71 Mil.

Biotika AS (XBRA:1BSL01AE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biotika AS (XBRA:1BSL01AE) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slovenskc Lupca 566, Banská Bystrica, SVK, 976 13

Website

https://www.biotika.sk

Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.

Biotika AS (XBRA:1BSL01AE) Headlines

No Headlines